WVE Q1 2025 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-26.8% YoY

Gross Profit

$7M76.4% margin

Operating Income

-$50M-542.8% margin

Net Income

-$47M-510.9% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

-89.0%

Cash Flow

Operating Cash Flow

-$63M

Free Cash Flow

-$63M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$288M

Total Liabilities

$117M

Stockholders' Equity

$172M

Cash & Equivalents

$243M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$13M	-26.8%
Gross Profit	$7M	$13M	-44.1%
Operating Income	-$50M	-$34M	-44.5%
Net Income	-$47M	-$32M	-48.5%